Stock Comparison

HLN vs UTHR

Haleon plc and United Therapeutics Corporation side by side — valuation, profitability, growth and risk.

Valuation

Market Cap
$40.72B
$23.03B
P/E (TTM)
18.9
20.1
Forward P/E
17.5
19.8
Price/Sales
3.7
7.3
Price/Book
1.9
3.9
EV/EBITDA
13.3
11.6
Dividend Yield
2.09%

Profitability

Net Margin
15.10%
40.60%
Operating Margin
23.20%
41.70%
Return on Equity
10.30%
20.30%
Return on Assets
4.67%
12.60%

Growth (YoY)

Revenue Growth
0.60%
-1.60%
Earnings Growth
92.00%
-12.20%

Price & Risk

Beta
0.2
0.6
52-Week High
$11.13
$609.35
52-Week Low
$8.60
$272.12
Analyst Target
$11.69
$665.23

Compare HLN and UTHR your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.